相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Independent trafficking of the KCNQ1 K+ channel and H+-K+-ATPase in gastric parietal cells from mice
Nhung Nguyen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
The Rediscovery of H-pylori Bacteria in the Gastric Mucosa by Robin Warren, and Implications of this Finding for Human Biology and Disease
Steven F. Moss
DIGESTIVE DISEASES AND SCIENCES (2013)
Omeprazole enhances the colonic expression of the Mg2+ transporter TRPM6
A. L. L. Lameris et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
The effects of varying acidity on Helicobacter pylori growth and the bactericidal efficacy of ampicillin
E. A. Marcus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Management of Helicobacter pylori infection-the Maastricht IV/ Florence Consensus Report
Peter Malfertheiner et al.
GUT (2012)
Omeprazole- and Esomeprazole-associated Hypomagnesaemia: Data Mining of the Public Version of the FDA Adverse Event Reporting System
Takao Tamura et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial
Peter Malfertheiner et al.
LANCET (2011)
Structure of the human histamine H1 receptor complex with doxepin
Tatsuro Shimamura et al.
NATURE (2011)
Characterization of a Novel Potassium-Competitive Acid Blocker of the Gastric H,K-ATPase, 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438)
Jai Moo Shin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease
R. H. HUNT
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Apical Recycling of the Gastric Parietal Cell H,K-ATPase
John G. Forte et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Monofumarate (TAK-438), a Novel and Potent Potassium-Competitive Acid Blocker for the Treatment of Acid-Related Diseases
Yasunobu Hori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Predictable prolonged suppression of gastric acidity with a novel proton pump inhibitor, AGN 201904-Z
R. H. Hunt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Helicobacter pylori colonization is inversely associated with childhood asthma
Yu Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Gene expression in vivo shows that Helicobacter pylori colonizes an acidic niche on the gastric surface
David R. Scott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Identification of the K efflux channel coupled to the gastric H-K-ATPase during acid secretion
NWG Lambrecht et al.
PHYSIOLOGICAL GENOMICS (2005)
Acid-adaptive genes of Helicobacter pylori
Y Wen et al.
INFECTION AND IMMUNITY (2003)
Oral esomeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects
D Armstrong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Therapeutic impact of CYP2C19 pharmacogenetics on proton pump inhibitor-based eradication therapy for Helicobacter pylori
T Furuta et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2003)
Tetany secondary to the use of a proton-pump inhibitor
V Subbiah et al.
ANNALS OF INTERNAL MEDICINE (2002)
Acid-induced gene expression in Helicobacter pylori:: Study in genomic scale by microarray
S Ang et al.
INFECTION AND IMMUNITY (2001)
分享论文
